Stability of Saccharated Ferric Oxide during Dilution

Saccharated Ferric Oxide-Induced Osteomalacia in Iron-Induced Osteopathy Due to Nephropathy

Adult-onset hypophosphatemic osteomalacia is very rare in well-developed countries [1]. The most likely diagnosis of such patients, if their diet contains enough vitamin D, is oncogenic or iatrogenic osteomalacia [2, 3]. Saccharated ferric oxide (SFO; [Fe(OH)3]m [C12H22O11]n) is an intravenous preparation indicated for patients with iron-deficiency anemia [4, 5]. Since its introduction into the...

Intravenous Iron Therapy with Saccharated Iron Oxide

A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome

RATIONALE Saccharated ferric oxide has been shown to lead to elevation of fibroblast growth factor 23, hypophosphatemia, and, consequently, osteomalacia. Moreover, mineral imbalance is often observed in patients with short-bowel syndrome to some degree. PATIENT CONCERNS A 62-year-old woman with short-bowel syndrome related with multiple resections of small intestines due to Crohn disease rece...

The immediate hematologic effects of intravenous saccharated iron oxide.

A Case of an Insufficiency Fracture of the Medial Proximal Tibia Secondary to Osteomalacia Associated with Long-Term Saccharated Ferric Oxide Administration

This article presents a case of insufficiency fracture of medial proximal tibia caused by long-term administration of saccharated ferric oxide (SFO) in a 77-year-old female. In this case, 2-year administration of SFO for iron deficit anemia induced hypophosphatemic osteomalacia and finally resulted in an insufficiency fracture of medial proximal tibia. Hypophosphatemia and pain due to the insuf...